Anadys Restructures, Focusing On Two Pipeline Candidates
This article was originally published in The Pink Sheet Daily
Executive Summary
Anadys abandons its lead candidate, ANA380, with rights reverting to LG Life Sciences, firm tells “The Pink Sheet” DAILY.